Monogram Orthopaedics, Inc.
MGRM · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $425 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $149 | $108 | $213 | $108 |
| Gross Profit | -$149 | -$108 | $213 | -$108 |
| % Margin | – | – | 50% | – |
| R&D Expenses | $2,257 | $2,258 | $1,743 | $2,215 |
| G&A Expenses | $772 | $1,032 | $1,119 | $1,093 |
| SG&A Expenses | $814 | $1,076 | $1,176 | $2,932 |
| Sales & Mktg Exp. | $42 | $44 | $58 | $1,839 |
| Other Operating Expenses | -$149 | $0 | $0 | $0 |
| Operating Expenses | $2,922 | $3,334 | $2,919 | $5,147 |
| Operating Income | -$3,071 | -$3,334 | -$2,919 | -$5,147 |
| % Margin | – | – | -686.1% | – |
| Other Income/Exp. Net | -$2,371 | $146 | -$1,330 | $113 |
| Pre-Tax Income | -$5,442 | -$3,188 | -$4,249 | -$5,035 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,442 | -$3,188 | -$4,249 | -$5,035 |
| % Margin | – | – | -998.7% | – |
| EPS | -0.16 | -0.096 | -0.13 | -0.16 |
| % Growth | -66.3% | 26% | 18.8% | – |
| EPS Diluted | -0.16 | -0.096 | -0.13 | -0.16 |
| Weighted Avg Shares Out | 35,512 | 35,211 | 32,571 | 32,224 |
| Weighted Avg Shares Out Dil | 35,512 | 35,211 | 32,571 | 32,224 |
| Supplemental Information | – | – | – | – |
| Interest Income | $129 | $146 | $214 | $113 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $149 | $108 | $109 | $108 |
| EBITDA | -$5,293 | -$3,226 | -$2,810 | -$5,039 |
| % Margin | – | – | -660.5% | – |